What have we learned from a case of convalescent plasma treatment in a two-time kidney transplant recipient COVID-19 patient? A case report from the perspective of viral load evolution and immune response

Coronavirus disease 2019 (COVID-19), an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, can have a wide range of clinical manifestations, ranging from asymptomatic disease to potentially life-threatening complications. Convalescent plasma therapy...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkki:	Aldunate, Fabian (author)
Eará dahkkit:	Fajardo, Alvaro (author), Ibañez, Natalia (author), Rammauro, Florencia (author), Daghero, Hellen (author), Arce, Rodrigo (author), Ferla, Diego (author), Pereira-Gomez, Marianoel (author), Salazar, Cecilia (author), Iraola, Gregorio (author), Pritsch, Otto (author), Hurtado, Javier (author), Tenzi, Jordan (author), Bollati-Fogolín, Mariela (author), Bianchi, Sergio (author), Nin, Nicolas (author), Moratorio, Gonzalo (author), Moreno, Pilar (author)
Materiálatiipa:	article
Giella:	eaŋgalasgiella
Almmustuhtton:	2023
Fáttát:	COVID-19 SARS-CoV-2 convalescent plasma therapy kidney transplant molecular diagnosis Ciencias Naturales y Exactas Ciencias Biológicas Virología Ciencias Médicas y de la Salud Medicina Básica Inmunología
Liŋkkat:	https://hdl.handle.net/20.500.12381/3465 https://doi.org/10.3389/fneph.2023.1132763
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!